Differences in immune infiltration between NAFLD and control groups. حسب Jiyong Zhang (2498740)

الموضوعات:

Enrichment Analysis Based on Ferroptosis-Related Differentially Expressed Genes. حسب Jiyong Zhang (2498740)

الموضوعات:

Correlation between hub genes and 50 hallmark signaling pathways. حسب Jiyong Zhang (2498740)

الموضوعات:

ROC curves for hub genes. حسب Jiyong Zhang (2498740)

الموضوعات:

Intersection genes obtained from the PPI network and PPI network analysis of intersection genes. colored circles represent genes. حسب Jiyong Zhang (2498740)

الموضوعات:

Expression profile heatmaps of key genes in gene sets. حسب Jiyong Zhang (2498740)

الموضوعات:

Construction of the WGCNA Co-expression Network. حسب Jiyong Zhang (2498740)

الموضوعات:

Differential Gene Expression Associated with Non-Alcoholic Fatty Liver Disease. حسب Jiyong Zhang (2498740)

الموضوعات:

Interaction analysis of hub genes. حسب Jiyong Zhang (2498740)

الموضوعات:

Crude and adjusted times and hazard ratios for child mortality. حسب Samuel Sendagala (21417164)

Basic characteristics included in the study. حسب Juan Gu (288925)

"…</p><p>Conclusions</p><p>Our meta-analysis indicates that a shorter time since the last birth is protective against endometrial cancer, whereas a longer interval increases risk. …"

Publication bias of the risk of all groups. حسب Juan Gu (288925)

"…</p><p>Conclusions</p><p>Our meta-analysis indicates that a shorter time since the last birth is protective against endometrial cancer, whereas a longer interval increases risk. …"

Study selection process. حسب Juan Gu (288925)

"…</p><p>Conclusions</p><p>Our meta-analysis indicates that a shorter time since the last birth is protective against endometrial cancer, whereas a longer interval increases risk. …"

Primary and secondary outcomes by treatment and time since randomization. حسب Jae-Heung Cho (798319)

Variation of the most appropriate p value significance threshold with different ratios of the standard deviations and sample sizes. حسب Farrokh Habibzadeh (12256529)

Shares of antibiotic substances on total prescription in UTI treatment (N39.0, N30.0) by sex and age group in 2019 (female: n = 238.670 prescriptions; male: n = 40.641 prescription... حسب Thomas Hanslmeier (19949694)

الموضوعات:

Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n... حسب Thomas Hanslmeier (19949694)

الموضوعات:

Shares of specialist groups prescribing 1^st, 2^nd, and 3^rd antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019. حسب Thomas Hanslmeier (19949694)

الموضوعات:

Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0). حسب Thomas Hanslmeier (19949694)

الموضوعات:

Shares of antibiotic substances on total prescription in female patients with UTI (N39.0, N30.0) by physician specialties (GPs: n = 1.299.641 prescriptions; gynecologists n = 141.8... حسب Thomas Hanslmeier (19949694)

الموضوعات: